Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA3 | O75311 | 1/20 | 0.46 |
| ▸ | GLRB | P48167 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | LDHA | P00338 | 5/20 | 0.41 |
| ▸ | LDHB | P07195 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SELL | P14151 | 2/20 | 0.36 |
| ▸ | SELP | P16109 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11712616 | 0.96 | GLRA3 (0.44) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL23164220 | 0.96 | GLRA3 (0.48) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL2910380 | 0.92 | DPP4 (0.43) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL28589381 | 0.89 | DPP4 (0.42) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL28343560 | 0.88 | GLRA3 (0.48) | GLRA3GLRBDPP4CA12CA1 | |
| Tert-Butanol SCHEMBL27810772 | 0.85 | GLRA3 (0.54) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL7260998 | 0.85 | DPP4 (0.43) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL19194174 | 0.83 | LDHA (0.52) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL8605888 | 0.83 | GLRA3 (0.37) | GLRA3GLRBDPP4CA12CA1 | |
| SCHEMBL19730665 | 0.83 | GLRA3 (0.37) | GLRA3GLRBDPP4CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490350-B | Cerium stabilized zirconia beads and process for preparing same | 浙江金琨西立锆珠有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-118367119-A | Organic matter modified carbon-based negative electrode material and manufacturing method thereof | 贵州创德新能源科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| EP-3749296-B1 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | ENZYMATICA AB (SE) | 2021-11-10 | — | — | EP | claimed |
| US-20210213112-A1 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | ENZYMATICA AB (SE) | 2021-07-15 | — | — | US | claimed |
| EP-3749296-A1 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | Enzymatica AB (SE) | 2020-12-16 | — | — | EP | claimed |
| CN-111655251-A | Esters of hydroxybenzoic acids for the treatment of rhinoviruses | 酶公司 | 2020-09-11 | — | — | CN | claimed |
| WO-2019154937-A1 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | ENZYMATICA AB (SE) | 2019-08-15 | — | — | WO | claimed |
| WO-2006009334-A1 | CYTOCHROME P450 ENZYME AND THE GENE ENCODING THE SAME | GENECHEM INC. (KR) | 2006-01-26 | — | — | WO | claimed |
| CN-119490350-B | Cerium stabilized zirconia beads and process for preparing same | 浙江金琨西立锆珠有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119490350-A | Cerium stabilized zirconia beads and process for preparing same | 浙江金琨西立锆珠有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118367119-A | Organic matter modified carbon-based negative electrode material and manufacturing method thereof | 贵州创德新能源科技有限公司 | 2024-07-19 | — | — | CN | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2022-10-13 | — | — | US | disclosed |
| US-20080262109-A1 | METHOD FOR PRODUCING LIQUID PREPARATIONS HAVING A SOLID BODY CONTENT | HENKEL AG & CO. KGAA (DE) | 2008-10-23 | — | — | US | disclosed |
| CN-101160378-A | Turbine fuel compositions exhibiting improved low temperature performance | BASF AG (DE) | 2008-04-09 | — | — | CN | disclosed |
| WO-2008005217-A2 | IRON(II)-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA | GENZYME CORPORATION (US) | 2008-01-10 | — | — | WO | disclosed |
| CN-100338152-C | Thixotropic agent comprising ethylene terpolymer wax | BASF AG (DE) | 2007-09-19 | — | — | CN | disclosed |
| WO-2006009334-A1 | CYTOCHROME P450 ENZYME AND THE GENE ENCODING THE SAME | GENECHEM INC. (KR) | 2006-01-26 | — | — | WO | disclosed |
| CN-1692145-A | Thixotropic agent comprising ethylene terpolymer wax | BASF AG (DE) | 2005-11-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | GLRA3 491/4885GLRB 591/4885DPP4 4876/4885 |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | SI, TAS2R7, TAS2R31 | GLRA3 777/4885GLRB 921/4885DPP4 281/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | GLRA3 777/4885GLRB 921/4885DPP4 281/4885 |
| US-20210213112-A1 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | HRH2, HRH4, CYP8B1 | GLRA3 788/4885GLRB 1887/4885DPP4 492/4885 |
| US-20080262109-A1 | METHOD FOR PRODUCING LIQUID PREPARATIONS HAVING A SOLID BODY CONTENT | AUP1, LIPC, FABP4 | GLRA3 3930/4885GLRB 4418/4885DPP4 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.